
|Articles|January 1, 2007
Combination BPH-OAB therapy controls symptoms
New York-Men bothered by overactive bladder and prostate enlargement symptoms who are treated simultaneously with the anticholinergic drug tolterodine tartrate extended-release capsules (Detrol LA) and the alpha-blocker tamsulosin (Flomax) report better symptom control and quality of life than do men treated with either one of the medications or placebo, according to a recently published study (JAMA 2006; 296:2319-28).
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
3
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
4
Amanda North, MD, recaps SWIU 2026 session on imposter syndrome
5






